By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GenoLogics today announced that it and Illumina have signed a worldwide co-selling agreement for the Geneus LIMS software.

Under the agreement, Illumina will market a version of the software pre-configured for its next-generation sequencers and TruSeq sample preparation kits. The pre-configured version will allow researchers to accelerate implementations, track library preparation and instrument runs, and prepare basic reports in weeks instead of months.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A Columbia University-led team used emergency contact information from medical records to create family trees and estimate disease heritability.

Parabon NanoLabs is partnering with law enforcement to use genetic genealogy approaches to solve cold cases, Buzzfeed News reports.

In Science this week: ancient Southeast Asian genomes provide insight on human migration, and more.

NPR says a new report recommends that former research chimpanzees should be moved to retirement sanctuaries unless that move would shorten their lives.

Jun
05
Sponsored by
Linguamatics

This webinar will discuss how Sanofi used literature mining to annotate the association of human leukocyte antigen (HLA) alleles with diseases and drug hypersensitivity as part of a multiple sclerosis (MS) biomarker discovery project.

Jun
12
Sponsored by
Philips Genomics

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.

Jun
14
Sponsored by
Sophia Genetics

This webinar will discuss an effort underway at the University of North Carolina Medical Center's to overcome limitations in the hematological genomic testing workflow with artificial intelligence (AI) from Sophia Genetics.

Jun
21
Sponsored by
Roche

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.